diclofenac has been researched along with Lymphoma, B-Cell in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diclofenac was started at a median of 20 hours (range 13-33) after fever onset." | 5.72 | Cytokine release syndrome after CAR infusion in pediatric patients with refractory/relapsed B-ALL: is there a role for diclofenac? ( Balduzzi, A; Bettini, L; Biondi, A; Bonanomi, S; Napolitano, S; Ottaviano, G; Rona, R; Rovelli, A; Russotto, V, 2022) |
| "Diclofenac was started at a median of 20 hours (range 13-33) after fever onset." | 1.72 | Cytokine release syndrome after CAR infusion in pediatric patients with refractory/relapsed B-ALL: is there a role for diclofenac? ( Balduzzi, A; Bettini, L; Biondi, A; Bonanomi, S; Napolitano, S; Ottaviano, G; Rona, R; Rovelli, A; Russotto, V, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Napolitano, S | 1 |
| Ottaviano, G | 1 |
| Bettini, L | 1 |
| Russotto, V | 1 |
| Bonanomi, S | 1 |
| Rovelli, A | 1 |
| Biondi, A | 1 |
| Rona, R | 1 |
| Balduzzi, A | 1 |
1 other study available for diclofenac and Lymphoma, B-Cell
| Article | Year |
|---|---|
Cytokine release syndrome after CAR infusion in pediatric patients with refractory/relapsed B-ALL: is there a role for diclofenac?
Topics: Child; Cytokine Release Syndrome; Diclofenac; Humans; Immunotherapy, Adoptive; Lymphoma, B-Cell; Pre | 2022 |